m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis
Open Access
- 3 November 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 16 (1) , 1-15
Abstract
N6-methyladenosine (m 6 A) modification has emerged as a common chemical modification in epigenetic regulation. However, whether this m 6 A modification is involved in glycolysis metabolism in pancreatic ductal adenocarcinoma (PDAC) remains elusive. Multiomics integration strategies, including metabolomics, m 6 A-seq and transcriptome sequencing, were utilized to evaluate the associations between m 6 A modifications and key processes of glucose metabolism in PDAC. Spontaneous PDAC mice (LSLKras G12D/+ , LSL-Trp53 R172H/+ , Pdx1-Cre; KPC) with FTO-conditional knockout and organoids were used to evaluate the effects of FTO stimulation on PDAC cell glycolysis and tumorigenesis. Series of in vivo and vitro functional analysis revealed that FTO promoted migratory capacity and glycolysis of PDAC cells. Mechanistically, FTO elevates the mRNA expression of the transcription factor C-Jun in a m 6 A-YTHDF2-dependent manner and further transcriptionally upregulates PFKM expression. Translational studies involving organoid models and xenograft tumor models revealed that the use of FTO inhibitors significantly suppressed PDAC growth. Our findings uncover that targeting the m 6 A-dependent FTO/C-Jun/PFKM glycolysis regulatory axis may be essential for the prevention and treatment of PDAC.Keywords
This publication has 37 references indexed in Scilit:
- Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancerCancer Cell, 2024
- Microenvironment drives cell state, plasticity, and drug response in pancreatic cancerCell, 2021
- Pancreatic CancerJAMA, 2021
- Selective activation of PFKL suppresses the phagocytic oxidative burstCell, 2021
- Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune EvasionCancer Cell, 2020
- A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNACell, 2020
- Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid LeukemiaCancer Cell, 2019
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesCancer Cell, 2019
- An Elongation‐ and Ligation‐Based qPCR Amplification Method for the Radiolabeling‐Free Detection of Locus‐Specific N6‐Methyladenosine ModificationAngewandte Chemie International Edition, 2018
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA SignalingCell, 2018